Gelonghui, March 13, 丨 Xinrui Pharmaceutical (06108.HK) issued an announcement. The board of directors will meet on March 25, 2024 to consider and approve the Group's annual results and publication for the year ended December 31, 2023, and to consider whether to pay a final dividend (if any).
新锐医药(06108.HK)将于3月25日举行董事会会议以审批全年业绩
Xinrui Pharmaceuticals (06108.HK) will hold a board meeting on March 25 to approve the annual results
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.